Introduction
The LumiSTAR iPSC Cell Therapy and Automation Pavilion brings together leading cell therapy companies and automation equipment manufacturers from Taiwan and Japan, offering cutting-edge automation solutions for iPSC-based therapies and exosome-related applications. Our integrated solutions span upstream technology development, cell expansion, differentiation, exosome isolation, and characterization, with advanced quality control (QC) methodologies utilizing high-content, high-throughput imaging for comprehensive functional cell testing. We provide tailored solutions to meet both research and clinical demands, with scalable offerings designed to suit the needs of different scales of cell manufacturing centers.
Features / strengths
- Enhanced Production Capacity: Automation systems enable continuous operation, significantly increasing overall production capacity.
- Improved Stability and Yield: Replacing manual processes with automated workflows ensures greater product consistency and higher yield.
- Simplified Licensing and Technology Transfer: Automation serves as an efficient platform for accelerating the licensing and technology transfer process.
- Scalability: Leveraging the pluripotency of iPSCs, the same automated systems can be scaled and adapted for future applications across various indications.
Specification in detail
